Sarepta Therapeutics Total Assets 2006-2019 | SRPT

Sarepta Therapeutics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Sarepta Therapeutics total assets for the quarter ending June 30, 2019 were $1.748B, a 40.14% increase year-over-year.
  • Sarepta Therapeutics total assets for 2018 were $1.642B, a 25.54% increase from 2017.
  • Sarepta Therapeutics total assets for 2017 were $1.308B, a 208.41% increase from 2016.
  • Sarepta Therapeutics total assets for 2016 were $0.424B, a 54.91% increase from 2015.
Sarepta Therapeutics Annual Total Assets
(Millions of US $)
2018 $1,642
2017 $1,308
2016 $424
2015 $274
2014 $295
2013 $292
2012 $205
2011 $54
2010 $46
2009 $60
2008 $26
2007 $39
2006 $41
2005 $56
Sarepta Therapeutics Quarterly Total Assets
(Millions of US $)
Q2 2019 $1,748
Q1 2019 $1,964
Q4 2018 $1,642
Q3 2018 $1,183
Q2 2018 $1,247
Q1 2018 $1,300
Q4 2017 $1,308
Q3 2017 $800
Q2 2017 $450
Q1 2017 $512
Q4 2016 $424
Q3 2016 $487
Q2 2016 $204
Q1 2016 $213
Q4 2015 $274
Q3 2015 $185
Q2 2015 $232
Q1 2015 $243
Q4 2014 $295
Q3 2014 $319
Q2 2014 $337
Q1 2014 $275
Q4 2013 $292
Q3 2013 $304
Q2 2013 $184
Q1 2013 $193
Q4 2012 $205
Q3 2012 $53
Q2 2012 $42
Q1 2012 $47
Q4 2011 $54
Q3 2011 $61
Q2 2011 $75
Q1 2011 $47
Q4 2010 $46
Q3 2010 $51
Q2 2010 $49
Q1 2010 $53
Q4 2009 $60
Q3 2009 $65
Q2 2009 $33
Q1 2009 $37
Q4 2008 $26
Q3 2008 $30
Q2 2008 $33
Q1 2008 $35
Q4 2007 $39
Q3 2007 $27
Q2 2007 $31
Q1 2007 $35
Q4 2006 $41
Q3 2006 $47
Q2 2006 $52
Q1 2006 $58
Q4 2005 $56
Q3 2005 $40
Q2 2005 $41
Q1 2005 $46
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.206B $0.301B
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.420B 13.72
Gilead Sciences (GILD) United States $81.040B 9.95
CSL (CSLLY) Australia $75.707B 0.00
Celgene (CELG) United States $71.278B 11.03
Illumina (ILMN) United States $44.479B 52.26
Vertex Pharmaceuticals (VRTX) United States $44.315B 47.89
Biogen (BIIB) United States $41.170B 7.31
Regeneron Pharmaceuticals (REGN) United States $33.034B 14.99
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.255B 11.73
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.371B 48.18
Seattle Genetics (SGEN) United States $13.358B 0.00
Genmab (GNMSF) Denmark $12.091B 67.82
BioMarin Pharmaceutical (BMRN) United States $12.089B 0.00
Exact Sciences (EXAS) United States $11.977B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.782B 0.00
Galapagos (GLPG) Belgium $8.522B 0.00
Bio-Techne Corp (TECH) United States $7.614B 52.60
QIAGEN (QGEN) Netherlands $6.107B 20.06
ACADIA Pharmaceuticals (ACAD) United States $5.855B 0.00
Guardant Health (GH) United States $5.723B 0.00
BeiGene (BGNE) Cayman Islands $5.672B 0.00
Amarin (AMRN) Ireland $5.437B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.045B 12.82
Exelixis (EXEL) United States $5.004B 13.01
Bluebird Bio (BLUE) United States $4.871B 0.00
Moderna (MRNA) United States $4.641B 0.00
China Biologic Products (CBPO) China $4.534B 28.30
ARGENX SE-ADR (ARGX) Netherlands $4.267B 0.00
Medicines (MDCO) United States $4.127B 0.00
Ascendis Pharma (ASND) Denmark $4.007B 0.00
Repligen (RGEN) United States $3.992B 77.46
Spark Therapeutics (ONCE) United States $3.841B 0.00
Blueprint Medicines (BPMC) United States $3.618B 0.00
MorphoSys AG (MOR) Germany $3.371B 0.00
Mirati Therapeutics (MRTX) United States $3.023B 0.00
Reata Pharmaceuticals (RETA) United States $2.884B 0.00
Alkermes (ALKS) Ireland $2.831B 0.00
Immunomedics (IMMU) United States $2.720B 0.00
Emergent Biosolutions (EBS) United States $2.713B 40.76
Genomic Health (GHDX) United States $2.563B 48.07
Genmab (GMAB) Denmark $2.508B 0.00
MyoKardia (MYOK) United States $2.470B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.350B 5.05
Halozyme Therapeutics (HALO) United States $2.348B 0.00
RA PHARMCTL INC (RARX) United States $2.188B 0.00
Myriad Genetics (MYGN) United States $2.180B 22.88
Acceleron Pharma (XLRN) United States $2.080B 0.00
NeoGenomics (NEO) United States $2.049B 109.61
CRISPR Therapeutics AG (CRSP) Switzerland $2.020B 0.00
Cambrex (CBM) United States $2.008B 25.39
Ligand Pharmaceuticals (LGND) United States $2.006B 25.37
Amicus Therapeutics (FOLD) United States $2.000B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.947B 0.00
Zai Lab (ZLAB) China $1.888B 0.00
Akcea Therapeutics (AKCA) United States $1.837B 0.00
UniQure (QURE) Netherlands $1.624B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.582B 0.00
Insmed (INSM) United States $1.552B 0.00
Denali Therapeutics (DNLI) United States $1.474B 0.00
REGENXBIO (RGNX) United States $1.454B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.340B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Coherus BioSciences (CHRS) United States $1.294B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.113B 0.00
Innoviva (INVA) United States $1.079B 3.12
Zymeworks (ZYME) Canada $1.077B 0.00
Alector (ALEC) United States $1.034B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.015B 0.00
Editas Medicine (EDIT) United States $1.000B 0.00
Sangamo Therapeutics (SGMO) United States $0.949B 0.00
AnaptysBio (ANAB) United States $0.948B 0.00
Fate Therapeutics (FATE) United States $0.932B 0.00
Epizyme (EPZM) United States $0.913B 0.00
ANI Pharmaceuticals (ANIP) United States $0.866B 14.46
Athenex (ATNX) United States $0.845B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.787B 27.86
Codexis (CDXS) United States $0.783B 0.00
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Cara Therapeutics (CARA) United States $0.754B 0.00
Twist Bioscience (TWST) United States $0.738B 0.00
Zealand Pharma (ZEAL) Denmark $0.733B 8.23
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.707B 365.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.689B 0.00
WAVE Life Sciences (WVE) Singapore $0.688B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 24.44
Cytokineticsorporated (CYTK) United States $0.656B 0.00
Vericel (VCEL) United States $0.638B 0.00
Mesoblast (MESO) Australia $0.617B 0.00
Arvinas (ARVN) United States $0.593B 0.00
Heska (HSKA) United States $0.569B 73.71
MiMedx (MDXG) United States $0.556B 0.00
Intellia Therapeutics (NTLA) United States $0.539B 0.00
Revance Therapeutics (RVNC) United States $0.537B 0.00
GENFIT S.A (GNFT) France $0.530B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.499B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.480B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.455B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.445B 0.00
Intra-Cellular Therapies (ITCI) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.425B 0.00
Cellectis S.A (CLLS) France $0.418B 0.00
DBV Technologies S.A (DBVT) France $0.407B 0.00
Stemline Therapeutics (STML) United States $0.385B 0.00
Arcus Biosciences (RCUS) United States $0.376B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Precision BioSciences (DTIL) United States $0.366B 0.00
Agenus (AGEN) United States $0.361B 0.00
Bellus Health (BLU) Canada $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 0.00
Adverum Biotechnologies (ADVM) United States $0.341B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.329B 24.35
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Prothena (PRTA) Ireland $0.310B 0.00
Gritstone Oncology (GRTS) United States $0.308B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
Geron (GERN) United States $0.288B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Theratechnologies (THTX) Canada $0.285B 0.00
Protagonist Therapeutics (PTGX) United States $0.284B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Scholar Rock Holding (SRRK) United States $0.279B 0.00
Puma Biotechnology (PBYI) United States $0.277B 0.00
PDL BioPharma (PDLI) United States $0.267B 6.88
Biofrontera AG (BFRA) Germany $0.265B 395.33
Dynavax Technologies (DVAX) United States $0.256B 0.00
Kindred Biosciences (KIN) United States $0.255B 0.00
MannKind (MNKD) United States $0.243B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.224B 0.00
Sutro Biopharma (STRO) United States $0.219B 0.00
Inovio Pharmaceuticals (INO) United States $0.216B 0.00
Seres Therapeutics (MCRB) United States $0.215B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.215B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Compugen (CGEN) Israel $0.214B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Sorrento Therapeutics (SRNE) United States $0.210B 0.00
Athersys (ATHX) United States $0.209B 0.00
Spero Therapeutics (SPRO) United States $0.206B 0.00
Kamada (KMDA) Israel $0.205B 7.85
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Exicure (XCUR) United States $0.192B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
Clovis Oncology (CLVS) United States $0.179B 0.00
Dyadic (DYAI) United States $0.176B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Enzo Biochem (ENZ) United States $0.174B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.171B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Cue Biopharma (CUE) United States $0.167B 0.00
Senesco Technologies (ELOX) United States $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.152B 0.00
Arsanis (XFOR) United States $0.146B 0.00
Cerecor (CERC) United States $0.138B 0.00
Northwest Biotherapeutics (NWBO) United States $0.137B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
NantKwest (NK) United States $0.123B 0.00
PHASEBIO PHARMA (PHAS) United States $0.119B 0.00
Acorda Therapeutics (ACOR) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.111B 0.00
Abeona Therapeutics (ABEO) United States $0.110B 0.00
Novavax (NVAX) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.109B 4.47
Paratek Pharmaceuticals (PRTK) United States $0.105B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Emmaus Life Sciences (EMMA) United States $0.100B 0.00
OvaScience (MLND) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.093B 0.00
VBI Vaccines (VBIV) United States $0.093B 0.00
Trevena (TRVN) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aduro Biotech (ADRO) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Verastem (VSTM) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
Mersana Therapeutics (MRSN) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.059B 21.59
Catabasis Pharmaceuticals (CATB) United States $0.058B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Stellar Biotechnologies (EDSA) Canada $0.044B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Unum Therapeutics (UMRX) United States $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Alimera Sciences (ALIM) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.024B 0.00
DiaMedica Therapeutics (DMAC) United States $0.022B 0.00
Caladrius Biosciences (CLBS) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Neuralstem (CUR) United States $0.002B 0.00